Abstract
Optimally, secondary cytoreduction is acknowledged as a valid option in terms of oncologic outcome for patients with platinum-sensitive recurrent ovarian cancer. In cases of localized relapse, a laparoscopic approach has been attempted at various institutions, but studies on its role for this subset of patients still are limited. This report describes the authors' experience using laparoscopic secondary cytoreduction for patients with localized recurrent ovarian cancer. The results from a retrospective analysis of a prospective case series are reported.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 1808-1815 |
| Numero di pagine | 8 |
| Rivista | Surgical Endoscopy |
| Volume | 28 |
| Numero di pubblicazione | 6 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2014 |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
-
SDG 3 Salute e benessere
All Science Journal Classification (ASJC) codes
- Chirurgia
Keywords
- Adjuvant
- Adult
- Aged
- Antineoplastic Agents
- Carcinoma
- Chemotherapy
- Disease-Free Survival
- Female
- Follow-Up Studies
- Humans
- Intraoperative
- Laparoscopy
- Laparotomy
- Length of Stay
- Local
- Lymph Node Excision
- Lymphatic Metastasis
- Middle Aged
- Monitoring
- Neoplasm Recurrence
- Neoplasm Staging
- Operative Time
- Ovarian Neoplasms
- Postoperative Complications
- Retrospective Studies
- Tissue Adhesions
Fingerprint
Entra nei temi di ricerca di 'Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver